Cited by 298

microRNA-34c is a novel target to treat dementias

Zovoilis, Athanasios, Agbemenyah, Hope Y, Agis‐Balboa, Roberto C, Stilling, Roman M, Edbauer, Dieter, Rao, Pooja, Farinelli, Laurent, Delalle, Ivana +6 more·2011·The EMBO Journal

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2011.327

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MiR-34a/c promotes apoptosis and impairs synaptic plasticity; their inhibition rescues memory in AD mouse models.

    “MiR-34a/c also promotes apoptosis and impair synaptic plasticity; their inhibition rescues memory in AD mouse models (Banzhaf-Strathmann et al., 2014; Sarkar et al., 2016; Zovoilis et al., 2011).”

    From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Zovoilis et al., 2011

  • AD is consistently associated with white-matter abnormalities and demyelination, contributing to cognitive and structural decline.

    “The disease is consistently associated with white-matter abnormalities and demyelination, contributing to cognitive and structural decline (Nasrabady et al., 2018; Zhou et al., 2022; Zovoilis et al., 2011).”

    From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Zovoilis et al., 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Papadopoulos P, Alexiou M, Maragkakis M, Reczko AG, Hatzigeorgiou AG (2009) DIANA-mirPath: integrating human microRNA-34c is a novel target to treat dementias A Zovoilis et al & 2011 European Molecular Biology Organization The EMBO Journal VOL 30 | NO 20 | 2011 4307 and mouse microRNAs in pathways GL. Bioinformatics 25: 1991 1993

Cited by

Sorted by citations

Authors
Zovoilis, A., Agbemenyah, H. Y., Agis‐Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., Bahari‐Javan, S., Burkhardt, S., Sananbenesi, F., & Fischer, A.
Venue
The EMBO Journal
Published
2011-09-23
Volume
30
Issue
20
Pages
4299-4308
ISSN
  • 0261-4189
  • 1460-2075
Cited by
298
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review